Article
A mouse model of severe halothane hepatitis based on human risk factors.
The Journal of pharmacology and experimental therapeutics - 1 May 2010
Dugan Christine M, MacDonald Allen E, Roth Robert A, Ganey Patricia E
Abstract excerpt
Halothane (2-bromo-2-chloro-1,1,1-trifluoro-ethane) is an inhaled anesthetic that induces severe, idiosyncratic liver injury, i.e., "halothane hepatitis," in approximately 1 in 20,000 human patients. We used known human risk factors (female sex, adult age, and genetics) as well as probable risk factors (fasting and inflammatory stress) to develop a murine model with characteristics of human halothane hepatitis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
